Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Acadia Healthcare | ACHC | Apr 18, 2024 | 70.28 | +0.04 |
Acadia Pharmaceuticals | ACAD | Apr 18, 2024 | 17.07 | -0.70 |
Acadia Realty Trust | AKR | Apr 18, 2024 | 16.75 | +0.66 |
Acasti Pharma A | ACST | Apr 18, 2024 | 3.07 | -3.76 |
Accel Entertainment | ACEL | Apr 18, 2024 | 11.26 | -0.18 |
Accelerate Diagnostics | AXDX | Apr 18, 2024 | 0.77 | +4.55 |
Accenture A | ACN | Apr 18, 2024 | 316.00 | +0.46 |
Acco Brands | ACCO | Apr 18, 2024 | 4.86 | +0.41 |
Accolade | ACCD | Apr 18, 2024 | 9.17 | +5.40 |
Accuray | ARAY | Apr 18, 2024 | 2.21 | +0.91 |
Ace Global Business Acquisition | ACBA | Apr 18, 2024 | 12.10 | -0.49 |
Ace Global Business Acquisition Unit | ACBAU | Apr 18, 2024 | 11.96 | 0.00 |
Acelyrin | SLRN | Apr 18, 2024 | 4.88 | -2.79 |
Achieve Life Sciences | ACHV | Apr 18, 2024 | 4.57 | 0.00 |
Achilles Therapeutics ADR | ACHL | Apr 18, 2024 | 0.80 | -1.78 |
ACI Worldwide | ACIW | Apr 18, 2024 | 31.51 | +0.06 |
Aclarion | ACON | Apr 18, 2024 | 0.30 | 0.00 |
Aclaris Therapeutics | ACRS | Apr 18, 2024 | 1.23 | 0.00 |
ACM Research A | ACMR | Apr 18, 2024 | 27.41 | -1.81 |
Acme United | ACU | Apr 18, 2024 | 43.01 | +0.58 |
ACNB | ACNB | Apr 18, 2024 | 31.10 | -0.96 |
Acorda Therapeutics | ACOR | Apr 18, 2024 | 0.88 | 0.00 |
ACRES Commercial Realty | ACR | Apr 18, 2024 | 13.66 | 0.00 |
ACRES Commercial Realty C Pref | ACR-C | Apr 18, 2024 | 23.82 | +1.40 |
ACRES Commercial Realty D Pref | ACR-D | Apr 18, 2024 | 20.35 | -0.05 |
Acrivon Therapeutics | ACRV | Apr 18, 2024 | 10.54 | +1.93 |
Actelis Networks | ASNS | Apr 18, 2024 | 0.68 | +1.33 |
Actinium Pharmaceuticals | ATNM | Apr 18, 2024 | 6.67 | -8.00 |
Active Bear ETF | HDGE | Apr 18, 2024 | 21.45 | -0.09 |
Active U.S. Real Estate Powershares | PSR | Apr 18, 2024 | 80.04 | +0.03 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.